Top Analyst Upgrades and Downgrades: Allergan, Lockheed Martin, Mylan, Nordstrom, Petrobras, NVIDIA, Western Digital and More

Investing

Published: May 13, 2016 8:40 am

Last Updated: January 13, 2020 8:07 am

Stocks were indicated lower on Friday the 13th, after a volatile Thursday. Investors have proven that they are still looking for opportunities and hidden gems, and so far they are more than willing to buy the big market dips.

24/7 Wall St. reviews dozens of analyst research reports each morning of the week. Our goal is to find new investing and trading ideas. Some of these analyst reports cover stocks to buy, and other reports feature stocks to sell or to avoid.

These are the top analyst upgrades, downgrades and initiations seen on Friday morning:

Allergan PLC (NYSE: AGN) was reiterated as Buy at Goldman Sachs, but the firm added Allergan to the prized Conviction Buy list. The stock closed most recently at $216.02. Allergan has a consensus analyst price target of $293.75 and a 52-week trading range of $195.50 to $340.34.

Lockheed Martin Corp. (NYSE: LMT) was downgraded to Hold from Buy at Stifel. Its shares closed at $244.94, and its consensus analyst target is $242.44. The 52-week range is $181.91 to $245.37.